Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -4.61% | -5.61% | -34.23% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.23% | 36Cr | |
+64.92% | 6.29TCr | |
-1.85% | 4.14TCr | |
+44.76% | 4.04TCr | |
-8.93% | 2.76TCr | |
+13.05% | 2.65TCr | |
-21.96% | 1.89TCr | |
+4.21% | 1.27TCr | |
+25.74% | 1.23TCr | |
+27.42% | 1.21TCr |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11